Mikael Eriksson

Sökresultat

• 2011

  Nordic MCL2 Trial of 1St-Line Intensive Immunochemotherapy and Autologous Stem Cell Transplantation in Mantle Cell Lymphoma: Still Encouraging Results After Median 5½ Years Observation Time

  Geisler, C. H., Kolstad, A., Laurell, A., Raty, R., Jerkeman, M., Eriksson, M., Nordstrom, M., Kimby, E., Bentzen, H. E. N., Nilsson-Ehle, H., Kuittinen, O., Lauritzsen, G. F., Ralfkiaer, E., Ehinger, M., Sundstrom, C., Delabie, J., Karjalainen-Lindsberg, M. -L., Pedersen, L. B., Andersen, N. S., Brown, P. D. N., & 1 andraElonen, E., 2011, I: Biology of Blood and Marrow Transplantation. 17, 2, s. 196-196

  Forskningsoutput: Tidskriftsbidrag › Publicerat konferensabstract › Peer review
• 2010

  Exon Based Transcriptome Profiling Reveals Genes That Have Prognostic Impact on the Survival of Young High Risk Diffuse Large B Cell/Follicular Grade 3 Lymphoma Patients Treated with Dose Dense Chemoimmuno therapy and CNS Prophylaxis Results From a Nordic Lymphoma Group Phase II Study

  Koivula, S., Taskinen, M., Chen, P., Holte, H., Delabie, J., Lindsberg, M. L. K., Bjorkholm, M., Fluge, O., Pedersen, L. M., Jerkeman, M., Eriksson, M., Hautaniemi, S. & Leppa, S., 2010, I: Blood. 116, 21, s. 1281-1281

  Forskningsoutput: Tidskriftsbidrag › Publicerat konferensabstract › Peer review

• High Serum Vascular Endothelial Growth Factor (VEGF) Level Is An Adverse Prognostic Factor In High Risk Diffuse Large B Cell Lymphoma (DLBCL) Patients Treated with Dose Dense Chemoimmunotherapy and Systemic CNS Prophylaxis Results From a Nordic Phase II Study

  Riihuarvi, S., Nyman, H., Holte, H., Bjorkholm, M., Fluge, O., Pedersen, L. M., Jerkeman, M., Eriksson, M. & Leppa, S., 2010, I: Blood. 116, 21, s. 1686-1686

  Forskningsoutput: Tidskriftsbidrag › Publicerat konferensabstract › Peer review
• 2009

  A European treatment protocol for bone sarcoma in patients older than 40 years

  Ferrari, S., Smeland, S., Bielack, S., Comandone, A., Dileo, P., Picci, P., Hall, K. S., Eriksson, M., Honegger, H. & Reichardt, P., 2009, I: Journal of Clinical Oncology. 27, 15

  Forskningsoutput: Tidskriftsbidrag › Publicerat konferensabstract › Peer review
• 2008

  R-CHOEP-14 X 6 Followed by Systemic CNS Prophylaxis for Diffuse Large B-Cell Lymphoma (DLBCL)/Follicular Lymphoma (FL) Grade 3 with Age Adjusted IPI Score 2-3: Preliminary Results of a Nordic Lymphoma Group (NLG) Phase 2 Study Including 160 Patients Aged 18-64 Years.

  Holte, H., Leppa, S. M., Bjorkholm, M., Fluge, O., Jyrkkio, S., Delabie, J., Sundstrom, C., Karjalainen-Lindsberg, M-L., Erlanson, M., Kolstad, A., Fossa, A., Ostenstad, B., Lofvenberg, E., Nordstroem, M., Moller-Pedersen, L., Anderson, H., Jerkeman, M. & Eriksson, M., 2008, I: Blood. 112, 11, s. 1233-1233

  Forskningsoutput: Tidskriftsbidrag › Publicerat konferensabstract › Peer review